by elasmogen | Dec 7, 2015 | Team
With postgraduate qualifications in both business and science, Caroline has a strong commercial, bio-partnering and biologics drug discovery/development background. She has successfully led teams at Wyeth Inc and subsequently Pfizer Inc in Global Bio-therapeutic...
by elasmogen | Dec 7, 2015 | Team
Andy was one of the founders of Elasmogen and as CTO manages the company’s extensive patent portfolio and IP strategy. He also holds a number of Non-Exec positions in Life Science and other businesses in Scotland. Andy is part-time Professor of Medical Biotechnology...
by elasmogen | Dec 8, 2015 | Team
Dr Savvas Neophytou is partner at Deepbridge Capital LLP where he heads up the firm’s Life Sciences business. Savvas also co-founded Acorn Partners, a joint venture between Deepbridge Capital, Alder Hey Hospital and software engineers WeAreNova. He is a founding...
by elasmogen | Dec 7, 2015 | Team
Dr Georg Buchner has over 10 years’ experience in Business and Corporate development. He has worked with various biotech companies in the UK and was Amgen’s Business Development Director covering the UK, Scandinavia and Israel. His deal experiences range from M&A...
